U
GILD icon

UBS’s Gilead Sciences GILD Stock Holding History

UBS’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$63.5M Buy
596,600
+194,000
+48% +$19M 0.05% 405
2014
Q2 		$33.4M Sell
402,600
-11,200
-3% -$872K 0.03% 626
2014
Q1 		$29.3M Buy
413,800
+285,900
+224% +$22.4M 0.03% 613
2013
Q4 		$9.61M Sell
127,900
-3,600
-3% -$251K 0.01% 1282
2013
Q3 		$8.27M Buy
131,500
+105,800
+412% +$6.32M 0.01% 1276
2013
Q2 		$1.32M Buy
+25,700
New +$1.34M ﹤0.01% 3008

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS's GILD Position: Q3 2014 in Review

UBS increased its Gilead Sciences (GILD) stake by 11% in Q3 2014, buying an estimated $55M and bringing the position to 5,836,112 shares worth $621M. The position accounts for 0.46% of the portfolio, ranked #27.

UBS first reported a position in GILD in Q2 2013 and has held it in 6 quarters since. 1,326 funds tracked by Wall St. Rank hold GILD as of Q3 2014.

  • UBS held 5,836,112 shares of Gilead Sciences worth $621M as of Q3 2014.
  • UBS bought 561,276 Gilead Sciences shares in Q3 2014, an estimated $55M.
  • Gilead Sciences made up 0.46% of UBS's portfolio in Q3 2014, its #27 holding.
  • UBS first reported a position in Gilead Sciences in Q2 2013 and has held it in 6 quarters since.
  • 1,326 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.